IASLC首次颁发患者关爱奖!广东省人民医院吴一龙教授团队获奖!
随着中国肺癌专家的研究频频登上ASCO、ESMO、WCLC的会场,中国学者越来越频繁地活跃在国际舞台上,影响力也显著提高。本次在日本举办的WCLC上,中国专家不仅斩获了顶级大奖,还有不少来自中国的青年研究者的研究被入选大会口头发言并获奖!让我们看一下本次WCLC都有哪些中国医生获奖呢?
IASLC首次颁发患者关爱奖!广东省人民医院吴一龙教授团队获奖!
在第18届世界肺癌大会(WCLC)的首次新闻发布会上,国际肺癌研究协会(IASLC)宣布了首届《IASLC患者关爱团队奖》的获奖名单。这是IASLC首次评选该奖项,以表彰在肺癌患者治疗过程中为患者提供卓越关心和优质护理的优秀多学科团队。
2017年IASLC基金会在全世界范围内遴选最卓越的肺癌患者关爱护理多学科团队,并在此次WCLC上颁发了首届癌症护理团队奖。该奖项由马修·霍尔曼博士及其妻子玛丽莲(肺癌幸存者)建立。
来自广东省人民医院广东省肺癌研究所的吴一龙教授团队(吴一龙教授、周清教授、张绪超教授、钟文昭教授、杨衿记教授等)荣获此项大奖
吴一龙教授、周清教授、张绪超教授、钟文昭教授上台领奖
首届《IASLC患者关爱团队奖》的获奖团队包括:
Guangdong Lung Cancer Institute (China)
Neotorax – Oncologia D´or (Brazil)
Instytut Gruźlicy i Chorób Płuc w Warszawie (Poland); Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii, Samodzielny Publiczny szpital Kliniczny w Warszawie (Poland); Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Warszawie (Poland)
Johns Hopkins Hospital – Sidney Kimmel Cancer Center (USA)
Rush University Medical Center (USA)
Tony Mok荣获“2017IASLC科学奖”(继吴一龙教授后又一华人斩获此奖项)
青年研究者奖(Young Investigator Travel Awards)
陈克终(Kezhong Chen)
【单位】中国北京大学人民医院 Peking University People's Hospital, China
【研究】OA 07.01: A Prospective STudy of Perioperative Rapid Clearance of Circulating Tumor DNA in RO Resected Non-Small Cell Lung Cancer Patients
*为第一届“35 under 35杰出青年肿瘤医生”获奖者
Developing National Travel Awards
【单位】广州医科大学第一附属医院,国家呼吸道疾病国家临床研究中心,中国国家呼吸道疾病重点实验室 The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, China State Key Laboratory of Respiratory Disease, China
【研究】MA 12.11: The Alteration of T790M Prevalence Between 19 Deletions and L858R in NSCLC After EGFR-TKIs Therapy, a Meta-Analysis
刘乾文(Qianwen Liu)
【单位】中山大学肿瘤医院 Sun Yat-sen University Cancer Center, China
【研究】OA 03.07: Developing Prognostic Nomogram and Evaluating Its Role in Personalized Adjuvant Chemotherapy for Patients with ESCC
【单位】复旦大学附属中山医院/上海市呼吸病研究所
Shanghai Respiratory Research Institute, China
【研究】MA 20.13: etDNA: Tumor-Derived DNA from Pleural Effusion Supernatant as a Promising Source for NGS-Based Mutation Profiling in Lung Cancer
岳东升(Dongsheng Yue)
【单位】天津医科大学肿瘤研究所/肿瘤医院 Tianjin Medical University Cancer Institute and Hospital, China
【研究】OA 16.04: Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
*为第一届“35 under 35杰出青年肿瘤医生”获奖者
【单位】同济大学医学院附属上海肺科医院 肿瘤科,Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, China
【研究】P3 15-015: LCNEC Tumor Location, Divided into Central and Peripheral Type, Has Distinct Clinicopathologic Feature, Genomic Characteristics and Survival
Patient Advocacy Awards
None
Nurse&Allied Health Travel Awards
【单位】Chi Mei Medical Center, Taiwan
【研究】P1 10-006: Adverse Events After First Line Target Therapy for Non-Small Cell Lung Cancer Pateints in a Case Management Model
International Mentorship Awards
【单位】广东省人民医院/广州省肺癌研究所/肿瘤中心 Division of Pulmonary Oncology, Cancer Center, Guangdong Lung Cancer Institute (GLCI), Guangdong General Hospital (GGH), China
【研究】P1 01-009: Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small Cell Lung Cancer
【单位】昆明动物学院,中国科学院(昆明)Institute of Zoology, University of Chinese Academy of Sciences, Kunming, China
【研究】P1 02-040: Genetic Risk Evaluation in Families with Lung Cancer History in High Lung Cancer Mortality Region of Xuanwei, China
【单位】广州医科大学第一附属医院,中国国家呼吸道疾病重点实验室,全国呼吸道疾病临床研究中心 The First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China
【研究】P3 02-008: Non-Invasive Diagnosis of Solitary Pulmonary Nodules Using High-Throughput Targeted DNA Methylation Sequencing of Circulating Tumor DNA
*为第一届“35 under 35杰出青年肿瘤医生”获奖者
【单位】广州医科大学第一附属医院 The First Affiliated Hospital of Guangzhou Medical University, China
【研究】MA 16.11: Alterations of Notch Pathway Among Patients with Adenoid Cystic Carcinoma of the Trachea and Its Impact on Survival
IASLC Academy Awards
none
Lectureship Awards
none
以上信息来自WCLC官方网站,如有疏漏或错误,请加小编微信:oncologynews 。
28个肿瘤相关临床试验招募患者
点击下方图片即可查看详情